购物车
您的购物车当前为空
MK-1220 is a novel Macrocyclic Inhibitor of Hepatitis C Virus NS3/4A Protease with Improved Preclinical Plasma Exposure.

MK-1220 is a novel Macrocyclic Inhibitor of Hepatitis C Virus NS3/4A Protease with Improved Preclinical Plasma Exposure.
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 25 mg | ¥ 22,700 | 10-14周 | |
| 50 mg | ¥ 30,300 | 10-14周 | |
| 100 mg | ¥ 39,500 | 10-14周 |
| 产品描述 | MK-1220 is a novel Macrocyclic Inhibitor of Hepatitis C Virus NS3/4A Protease with Improved Preclinical Plasma Exposure. |
| 分子量 | 779.94 |
| 分子式 | C40H53N5O9S |
| CAS No. | 924270-31-5 |
| Smiles | N(C(=O)[C@H]1N2C[C@@](C1)(OC3=C4C(C=C(OC)C(=C4)CCCC(C)(C)COC(=O)N[C@H](C2=O)C5CCCCC5)=CC=N3)[H])[C@@]6(C(NS(=O)(=O)C7CC7)=O)[C@H](C=C)C6 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
对于不同动物的给药剂量换算,您也可以参考 更多